Alnylam Pharma (ALNY) – Guidance
-
Alnylam Pharma (ALNY) Tops Q4 EPS by 49c; offers guidance
-
Alnylam Pharma (ALNY) Reports Prelim Q4 and FY23 Global Net Product Revenues
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to ALNY Stock Lookup